Cargando…

Clinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical cancer: current evidence

The addition of bevacizumab to established therapies for metastatic and locally advanced cervical cancer is an area of evolving research and a potential strategy toward improving historically suboptimal outcomes for women with advanced disease. Bevacizumab, when added to first-line chemotherapy, has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jackson, Matthew W, Rusthoven, Chad G, Fisher, Christine M, Schefter, Tracey E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037327/ https://www.ncbi.nlm.nih.gov/pubmed/24876784 http://dx.doi.org/10.2147/OTT.S49429

Ejemplares similares

Profile of bevacizumab and its potential in the treatment of cervical cancer
por: Fisher, Christine M, et al.
Publicado: (2015)

Addition of bevacizumab to systemic therapy for locally advanced and metastatic nasopharyngeal carcinoma
por: Zhang, Hui-Jie, et al.
Publicado: (2018)

Breaking down the evidence for bevacizumab in advanced cervical cancer: past, present and future
por: Rodriguez-Freixinos, Victor, et al.
Publicado: (2015)

Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer
por: Ercelep, Özlem, et al.
Publicado: (2020)

Efficacy of Bevacizumab Combined with Pemetrexed in the Treatment of Recurrent and Metastatic Cervical Cancer
por: He, Ying, et al.
Publicado: (2022)

Current status of bevacizumab in advanced ovarian cancer
por: Tomao, Federica, et al.
Publicado: (2013)

Bevacizumab Eligibility in Patients with Metastatic and Recurrent Cervical Cancer: A Retrospective Review
por: Skelton, William Paul, et al.
Publicado: (2018)

Cost Effectiveness of Bevacizumab Plus Chemotherapy for the Treatment of Advanced and Metastatic Cervical Cancer in India—A Model-Based Economic Analysis
por: Gupta, Nidhi, et al.
Publicado: (2022)

Gastrointestinal Perforation With an Intraluminal Stent and Bevacizumab use in Advanced Metastatic Colorectal Cancer
por: Akeel, Nouf, et al.
Publicado: (2021)

Immune checkpoint blockade for locally advanced or recurrent/metastatic cervical cancer: An update on clinical data
por: Song, Zhuo, et al.
Publicado: (2022)

Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis
por: Foster, Corey C., et al.
Publicado: (2019)

Bevacizumab in Advanced Cervical Cancer: Issues and Challenges for Low- and Middle-Income Countries
por: Gyawali, Bishal, et al.
Publicado: (2016)

Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer
por: Friedman, Claire F, et al.
Publicado: (2020)

Biological response modifiers and infectious diseases: Actual and potential therapeutic agents
por: Rusthoven, James J.
Publicado: (1994)

Current use and potential role of bevacizumab in the treatment of gastrointestinal cancers
por: Li, Jia, et al.
Publicado: (2009)

Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars
por: Rosen, Lee S., et al.
Publicado: (2017)

Pembrolizumab in the treatment of locally advanced or metastatic urothelial carcinoma: clinical trial evidence and experience
por: Crist, Michael, et al.
Publicado: (2019)

Severe hematuria in a patient receiving bevacizumab and pembrolizumab for metastatic cervical cancer: a case report
por: Liu, Yanxin, et al.
Publicado: (2023)

Strategies to Preserve Cognition in Patients With Brain Metastases: A Review
por: Robin, Tyler P., et al.
Publicado: (2018)

Radiosurgery for small-cell lung cancer brain metastases: a review
por: Robin, Tyler P., et al.
Publicado: (2020)

A single-arm study evaluating bevacizumab, cisplatin, and paclitaxel followed by single-agent bevacizumab in Japanese patients with advanced cervical cancer
por: Sugiyama, Toru, et al.
Publicado: (2017)

Paclitaxel, Carboplatin, and Bevacizumab in Advanced Cervical Cancer: A Treatment Response and Safety Analysis
por: Tao, Wanjun, et al.
Publicado: (2020)

Efficacy and safety of bevacizumab biosimilar compared with reference bevacizumab in locally advanced and advanced non-small cell lung cancer patients: A retrospective study
por: Zhao, Zhiting, et al.
Publicado: (2023)

Surgical Staging of Locally Advanced Cervical Cancer: Current Status and Research Progress
por: Zhang, He, et al.
Publicado: (2022)

Postoperative chemoradiotherapy versus radiotherapy alone for elderly cervical cancer patients with positive margins, lymph nodes, or parametrial invasion
por: Cushman, Taylor R., et al.
Publicado: (2018)

Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer
por: Haslam, Sonya, et al.
Publicado: (2007)

Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer
por: Miyagawa, Yoshimasa, et al.
Publicado: (2020)

Bevacizumab plus cisplatin and helical tomotherapy in treatment of locally advanced nasopharyngeal carcinoma
por: Li, Jianxiong, et al.
Publicado: (2015)

Real-world efficacy and safety of bevacizumab single-maintenance therapy following platinum-paclitaxel chemotherapy plus bevacizumab in patients with advanced cervical cancer
por: Kotaka, Saki, et al.
Publicado: (2023)

Bevacizumab in the therapy for refractory metastatic colorectal cancer
por: Mulcahy, Mary F
Publicado: (2008)

Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer
por: Koudriavtseva, Tatiana, et al.
Publicado: (2021)

Intravitreal bevacizumab: an analysis of the evidence
por: Smit, Derrick P, et al.
Publicado: (2007)

Histopathological features predict metastatic potential in locally advanced colon carcinomas
por: Jayasinghe, Caren, et al.
Publicado: (2015)

Advances in diagnosis and treatment of metastatic cervical cancer
por: Li, Haoran, et al.
Publicado: (2016)

Advances in management of locally advanced cervical cancer
por: Musunuru, Hima Bindu, et al.
Publicado: (2021)

Prophylactic cranial irradiation or MRI surveillance for extensive stage small cell lung cancer
por: Taylor, James M., et al.
Publicado: (2020)

Two Cases of Mastectomy after Paclitaxel + Bevacizumab Therapy for Locally Advanced Breast Cancer
por: Shinoda, Chika, et al.
Publicado: (2014)

Treatment of NRAS-mutated advanced or metastatic melanoma: rationale, current trials and evidence to date
por: Boespflug, Amélie, et al.
Publicado: (2017)

Efficacy of Adding Bevacizumab in the First-Line Chemotherapy of Metastatic Colorectal Cancer: Evidence from Seven Randomized Clinical Trials
por: Chen, Yan-xian, et al.
Publicado: (2014)

Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis
por: Ilic, Irena, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oe1inho01fk1p78ng5q6i1k1gu